METHOD FOR TREATING MEMBRANOUS NEPHROPATHY WITH TACI-FC FUSION PROTEIN
Application
US20260098077A1
Kind: A1
Apr 09, 2026
Inventors
Xiangdong YANG, Ling GUO, Dengren LI, Jianmin FANG, Wenxiang WANG
Abstract
The present disclosure relates to a drug, a dosage scheme, an administration interval, and an administration mode for treating membranous nephropathy with a TACI-Fc fusion protein. Results show that the TACI-Fc fusion protein provided by the present disclosure shows relatively good clinical curative effect and good safety in the process of treating a patient with membranous nephropathy.
CPC Classifications
C07K 14/70578
A61K 9/0019
A61P 13/12
A61P 37/06
A61K 38/00
C07K 2319/30
Filing Date
2023-09-28
Application No.
19114798